Technology Commercialization Office

Showing 11 result(s) for "Diagnostics"



Prognostic Indications of Canine Lymphoid Neoplasia using plasma DNA assays.

Realistic immunohistochemical stained tissue section databases for training, certification, and machine standards.

A non-invasive and automated tumor budding image analysis system for colorectal cancer. This program can detect tumor buds in traditional H&E stained sections without the need for manual assessment.

A diagnostic to provide more swift and reliant detection of Alzheimer's disease by monitoring the chemical modification of tau proteins in bodily fluids.

An enhanced nucleic acid amplification system that is more efficient and cost-effective than conventional polymerase chain reaction methods.

Polymethylmethacrylate (PMMA) is a useful material for development of assays, biochips, and other biological materials. However, PMMA makes for a difficult substrate because of complexities with respect to adhesion. This technology presents two new methods for enhanced protein binding onto PMMA.

A simple, and efficient method for identifying intra-cellular biomarkers for the targeted treatment of disease.

Discovery of microvesicles containing microRNA from myeloid cells that can serve as biomarkers and molecular targets

A more accurate, cost efficient and faster method to one of the most widely used diagnostic tests in the world.

A rapid diagnostic test for Thrombotic Thrombocytopenic Purpura.